Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New Metabiogenix brochure from the company $INQD acquired.
Source: https://twitter.com/trenskee/status/1678901404306493442;
It is good we don't have any gaps to worry about in the chart for $INQD. A slow and steady move up it seems IMO.
Great $INQD news out!
Indoor Harvest Corp. Expands its Portfolio with the Acquisition of 60% Controlling Interest in Metabiogenix USA®
From Japan to Mexico to the World: “The Metabolism for Life”
AUSTIN, May 08, 2023 (GLOBE NEWSWIRE) -- Indoor Harvest Corp. (OTCPK: INQD) (the “Company") a company of sustainable-hemp and wellness related products, is pleased to announce the acquisition of a 60% controlling interest in Metabiogenix USA® for $2.5M in a combination of cash and common stock. During the close of the acquisition, Metabiogenix USA® received a valuation of $8.9M USD from the Japanese Medical Institute (JMI).
“This acquisition will provide Indoor Harvest an exclusive agreement to market and distribute the portfolio of Metabiogenix USA® Nutraceuticals throughout the entire Western Hemisphere (North, South, and Central America), and Spain. Metabiogenix USA® is on track for substantial growth and projecting revenues that could be as high as $20M for FY2024” said Leslie Bocskor, Chairman & CEO of INQD. “Words cannot express the gratitude I am experiencing to have Dr. Mario Acosta Mejia join Indoor Harvest and look forward to working with him to develop this paradigm shifting class of health and wellness products as he continues to lead Metabiogenix USA®.”
With the evolution of wellness and health technologies built from the foundation of Probiotics, a new generation of Metabiotics has been developed by the Japanese Medical Institute to work towards improving the life expectancy and quality of life to people around the world. Japan currently has the longest life expectancy with the average lifespan of 87 years. Dr. Mario Acosta Mejia, Co-Founder and President of Metabiogenix USA®, was among the original Principal Clinical Investigators at the Japanese Medical Institute and was instrumental in developing Metabiox®.
“After years of working with my counterparts in Japan, Mexico, and Europe to develop this new class of health and wellness products, we will continue to revolutionize preventative methods around the world by bringing education and tools to doctors and medical practitioners as these patented products continue to evolve,” said Dr. Mario Acosta Mejia. “I am honored to join the Indoor Harvest family and looking forward to leading Metabiogenix USA® and educating the world about “The Metabolism of Life!”.
Dr. Acosta completed his Ph.D. in Clinical Pharmacology from the University of Cambridge England where he was honored as "Distinguished Graduate of the 20th Century". He has been an Academic and Researcher at various Universities in Mexico and has presented at more than 2,000 conferences. Dr. Acosta has authored four (4) books; two (2) on Pharmacology, one (1) on Public Health and one (1) on Medical Humanism. In 2013, he received the Award as "One of the 30 Brilliant Minds of Mexico" by Discovery Channel and Grupo Expansión, from Nobel Prize winner Mario Molina. Dr. Acosta is the Founder and National President of the Alianza Médica Fraternity, which brings together more than 30,000 Doctors throughout Mexico. He is currently General Director of the Center for Bioequivalence Studies as well as Principal Clinical Investigator at the Japanese Medical Institute in Tokyo, Japan.
As part of the acquisition, Dr. Acosta will be retained under a new developing employment agreement as President of Metabiogenix USA®.
About Metabiogenix USA®:
Metabiogenix USA® is the officially licensed distributor of Metabiox® across the Western Hemisphere (North, South, and Central America), and Spain. Metabiox® was developed by the Japanese Medical Institute and is produced in Japan.
Metabiox® was certified in December 2021 by COFEPRIS (United Mexican States Federal Committee for Protection from Sanitary Risks), which is Mexico’s equivalent to the US Food & Drug Administration, as a new class of therapeutics. After 10 years of extensive research, several clinical trials in Japan and Mexico, Metabiox® has helped thousands of patients in Mexico:
Regulate cellular metabolism throughout the body (metabolic disease control)
Restore Metabolism and pancreatic function (pancreatic reset program)
Reverse Inflammation and markers of liver dysfunction
Reinforces intestinal motility, nutrient absorption, and immune system
Reset the sleep-wake cycle
About Japanese Medical Institute:
The Japanese Medical Institute was created to focus on bringing innovations to market leaders. The foundation of the company started on the discovery of the importance of gut microbiome synchronization with the interaction with the different microbiome axis in the body (brain, pancreas, liver, immune system, skin, and others) with the consequent potentiation in the management, control and in some cases remission of chronic degenerative diseases as well as life expectancy and maintenance of health in humans (Lifespan and Health span).
About Indoor Harvest:
Indoor Harvest Corp. (OTCPK: INQD) is a company of sustainable-hemp and wellness related products. The Company incorporates development of proprietary technology, mergers, acquisitions, strategic partnerships, and joint ventures as part of a broad integration strategy. INQD cultivates partnerships within related industries, providing an opportunity to be part of a more significant play, sharing intellectual capital, technology, access to new capital markets, and liquidity for owners.
Forward Looking Statements: This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as “expect,” “feel,” “believe,” “will,” “may,” “should,” “anticipate,” “intend,” “estimate,” “project,” “forecast,” “plan” and similar expressions are intended to identify forward-looking statements. These statements include but are not limited to financial projections and estimates and their underlying assumptions; statements regarding plans, objectives, and expectations with respect to future operations, products, and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward- looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent otherwise required by federal securities laws, we do not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof. Risks include but are not limited to general risks associated with mergers, acquisitions, joint ventures, and strategic alliances; lack of sufficient capital, changes in U.S. hemp and related laws; possible impairment of assets, COVID and more.
Source: https://finance.yahoo.com/news/indoor-harvest-corp-expands-portfolio-100000343.html
Looking forward to $INQD setting a new 52 week high this week.
Source: https://www.barchart.com/stocks/quotes/INQD/cheat-sheet
Almost closed at the high of the day. $INQD has a very strong shareholder base. It is very important to know what you own. Looking forward to next week it will be very exciting IMO.
This is great exposure for $INQD. The news below was picked up by Benzinga.
Indoor Harvest Corp. Acquires 369Hemp, Plans To Expand Into Smokable Hemp Market
by
Joana Scopel, Benzinga Staff Writer
May 1, 2023 2:41 PM |
Indoor Harvest Corp. $INQD announced the completion of its acquisition of Opportunity Development Group, LLC, and its subsidiary, 369Hemp, Inc., a hemp cigarette manufacturer.
Leslie Bocskor, CEO and chairman of INQD expressed excitement about the acquisition, stating that they are confident they will immediately reap the rewards from 369Hemp's team and technology to market, manufacture, and distribute hemp cigarettes globally.
“We believe there is vast opportunity in this space and by capturing just a small percentage of the North American market we will be a strong contender in smokeable hemp."
The acquisition was made for a combination of cash and common stock. Travis Priddy, the founder and CEO of 369Hemp will be retained as president of 369Hemp under a new employment agreement.
Priddy shared his enthusiasm, saying that they “have created an authentic, true-quality alternative cigarette to what most smokers are currently accustomed to with manufacturing efficiency at speeds to scale.”
369Hemp brands include 369Hemp and white-labeled hemp cigarettes, and its distribution model consists of online direct-to-consumer, in-store retail, and wholesale markets.
Indoor Harvest's acquisition of 369Hemp is set to strengthen its foothold in the smokable hemp market, which is projected to reach $300-400 million by 2025, per Hemp Industry Daily.
Source: https://www.benzinga.com/markets/cannabis/23/05/32129592/indoor-harvest-corp-acquires-369hemp-plans-to-expand-into-smokable-hemp-market
A completed acquisition $INQD isn't messing around.
Indoor Harvest Corp. Announces Completion of Acquisition of 369Hemp®
Source: https://finance.yahoo.com/news/indoor-harvest-corp-announces-completion-120000193.html
I like that $INQD has no gaps to fill so it can run freely:)
Source: http://www.stockta.com/cgi-bin/analysis.pl?symb=INQD&cobrand=&mode=stock
A green close is always good getting close to a .01 break. Go $INQD
Great Purchase by $INQD Looking forward to learning more about this acquired company.
I like the strength $INQD is showing. Looking forward to seeing $INQD hit a new 52 week high this year.
Source: https://www.barchart.com/stocks/quotes/INQD/cheat-sheet
I feel that the force is still with $INQD The company is in a great industry and it is just a matter of time IMO that the market will notice the company.
Looks like a great hire for $INQD
This is what you want to see on $INQD Higher Highs and higher lows too:)
Date Close Change Change (%) Open High Low Volume
Apr 18 2023 0.0078 0.0004 5.41% 0.0077 0.0084 0.0071 7,643,592
Apr 17 2023 0.0074 0.00055 8.03% 0.0073 0.008 0.0067 4,659,827
Apr 14 2023 0.00685 0.0009 15.13% 0.0061 0.0072 0.0061 8,448,806
Apr 13 2023 0.00595 -0.00015 -2.46% 0.0061 0.0063 0.00575 932,529
Good to see some of the $INQD private placements are close to the current stock range.
During the year ended December 31, 2022, the Company issued 117,280,154 shares of common stock as follows:
116,446,154 shares of common stock for the private placements at $0.005 and $0.0065 per share for cash of $600,000.
Private Placement
On February 16, 2022 and March 16, 2022, the Company initiated a private placement offering for the sale of up to 150,000,000 shares of the Company’s common stock, at price of $0.006 per share, for total consideration to the Company of $900,000. On May 12, 2022, the issuance price was updated to $0.005 per share.
On August 1, 2022, the Company initiated a private placement offering for the sale of up to 123,076,923 shares of the Company’s common stock, at price of $0.0065 per share and an equal number of Warrants with an exercise price of $0.013 for total consideration to the Company of $800,000. On August 12, 2022 and November 9, 2022, the number of shares was updated to 153,846,154 (for total consideration to the Company of $1,000,000) and 200,000,000 shares (for total consideration to the Company of $1,300,000) an equal number of Warrants with an exercise price of $0.013, respectively.
Source: https://www.otcmarkets.com/filing/html?id=16535756&guid=mEm-kWz4RHyVh3h
Looking good BahamaPete. Looking forward to seeing what $INQD does with the Private placement money.
Looks like the force is with $INQD it has been holding well on no news. Support is building in the .006 range. Looking forward to the next $INQD update.
Thanks BahamaPete. That is good to know. Looks like based on the most recent 10-K financial disclosure OTC Markets feels $INQD isn't a shell risk company any longer.
The OTC Markets Group may classify a company as a Shell Risk if the company has financial or other characteristics of a shell company. This classification is assigned subjectively based on a company's financial disclosures and is not based on companies' self-reported shell status.
In the 10-K $INQD stated they were not a shell company any longer. This change was reflected sometime after on OTC Markets.
Source: https://www.otcmarkets.com/filing/html?id=16535756&guid=rmm-kpbZrId_V3h
Great News that the shell risk is removed! Go $INQD
What does a shell risk mean on OTC markets?
The Shell Risk designation warns that a company displays characteristics common to shell companies based on an analysis of the company's key annual financial data. Shell companies have no or minimal assets and operations.
Standard purchase agreement language IMO. No litigation tied to the Asset Purchase Agreement.
Source: https://www.sec.gov/Archives/edgar/data/1572565/000149315223006357/ex2-1.htm
From the 10K filing.
Item 3. Legal Proceedings.
From time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. The Company may be subject to one or more claims or suits but to our best and current knowledge, there are no current suits at this time.
Source: https://www.otcmarkets.com/filing/html?id=16535756&guid=d_m-kpd9M-yeJth
Filing that audited 10K on time is telling the market $INQD is getting their house in order. I am ready to see them build on that foundation soon.
An audited 10-K on time way to go $INQD
I like the $INQD bid support today. Hopefully a new barcoding range will be established in the .006 range until acquisition news hits.
Good to see $INQD holding in the .005 range. The PR hinted of possible news in the near future.
The PR sounds like LB is building a good foundation for the future. $INQD
The new $INQD Sheriff is in town:)
Glad to see MICHAEL BLICHARSK fighting back. $INQD
I agree the issue needs to be addressed. LB hasn't done any public relations yet that I am aware of so hopefully when he starts he will address this issue. $INQD
I agree with you about the company putting our a PR along with an 8K. I have seen 8K's that have links to PR's within them. The company is only required to put out an 8K for a material event but a PR explaining the 8K in layman's terms would help a lot IMO. $INQD